Abstract:The role of various matrix metalloproteinases (MMP)--such as gelatinases, stromelysins, matrilysin, collagenase-3, and membrane-bound MMP (MB-MMP)--in tumor invasion and metastasis is discussed. Data suggesting significance for malignant growth of the expression level of these enzymes and also of their activators and inhibitors are presented. It is concluded that at different stages of tumor progression the activity of different MMPs is displayed, which is regulated by various growth factors and oncogenes. Dif… Show more
“…MMPs that are highly expressed in various malignant tumors have been recognized as playing an important role in cell motility and invasion via the degradation of ECM components of blood or lymph vessels (Khasigov et al ., 2003; Hanahan and Weinberg, 2011). Gelatinase types of MMPs such as MMP-2 and -9 promote tumor cell invasion in various cancer cell lines because of their ability to degrade various types of collagens (Vu and Werb, 2000; Egeblad and Werb, 2002).…”
Section: Discussionmentioning
confidence: 99%
“…Metastasis is a highly coordinated multistep process, of which degradation of the extracellular matrix (ECM) is an important component (Khasigov et al ., 2003; Hanahan and Weinberg, 2011). Through degradation of the ECM, cancer cells escape the primary tumor, penetrate the basement membrane of capillary and lymphatic vessels, intravasate, and migrate to new locations in the body (Yilmaz et al ., 2007; Valastyan and Weinberg, 2011).…”
Section: Introductionmentioning
confidence: 99%
“…Through degradation of the ECM, cancer cells escape the primary tumor, penetrate the basement membrane of capillary and lymphatic vessels, intravasate, and migrate to new locations in the body (Yilmaz et al ., 2007; Valastyan and Weinberg, 2011). Matrix metalloproteinases (MMPs), a family of zinc-dependent endopeptidases, are crucial molecules in the degradation of ECM and affect the invasion of cancer cells (Khasigov et al ., 2003; Kessenbrock et al ., 2010). Among the MMPs, MMP-2 (gelatinase A) and -9 (gelatinase B) play pivotal roles in the process of ECM degradation (Vu and Werb, 2000; Egeblad and Werb, 2002).…”
Baicalein, a natural flavonoid obtained from the rhizome of Scutellaria baicalensis Georgi, has been reported to have anticancer activities in several human cancer cell lines. However, its antimetastatic effects and associated mechanisms in melanoma cells have not been extensively studied. The current study examined the effects of baicalein on cell motility and anti-invasive activity using mouse melanoma B16F10 cells. Within the noncytotoxic concentration range, baicalein significantly inhibited the cell motility and invasiveness of B16F10 cells in a concentration-dependent manner. Baicalein also reduced the activity and expression of matrix metalloproteinase (MMP)-2 and -9; however, the levels of tissue inhibitor of metalloproteinase-1 and -2 were concomitantly increased. The inhibitory effects of baicalein on cell motility and invasiveness were found to be associated with its tightening of tight junction (TJ), which was demonstrated by an increase in transepithelial electrical resistance and downregulation of the claudin family of proteins. Additionally, treatment with baicalein markedly reduced the expression levels of lipopolysaccharide-induced phosphorylated Akt and the invasive activity in B16F10 cells. Taken together, these results suggest that baicalein inhibits B16F10 melanoma cell migration and invasion by reducing the expression of MMPs and tightening TJ through the suppression of claudin expression, possibly in association with a suppression of the phosphoinositide 3-kinase/Akt signaling pathway.
“…MMPs that are highly expressed in various malignant tumors have been recognized as playing an important role in cell motility and invasion via the degradation of ECM components of blood or lymph vessels (Khasigov et al ., 2003; Hanahan and Weinberg, 2011). Gelatinase types of MMPs such as MMP-2 and -9 promote tumor cell invasion in various cancer cell lines because of their ability to degrade various types of collagens (Vu and Werb, 2000; Egeblad and Werb, 2002).…”
Section: Discussionmentioning
confidence: 99%
“…Metastasis is a highly coordinated multistep process, of which degradation of the extracellular matrix (ECM) is an important component (Khasigov et al ., 2003; Hanahan and Weinberg, 2011). Through degradation of the ECM, cancer cells escape the primary tumor, penetrate the basement membrane of capillary and lymphatic vessels, intravasate, and migrate to new locations in the body (Yilmaz et al ., 2007; Valastyan and Weinberg, 2011).…”
Section: Introductionmentioning
confidence: 99%
“…Through degradation of the ECM, cancer cells escape the primary tumor, penetrate the basement membrane of capillary and lymphatic vessels, intravasate, and migrate to new locations in the body (Yilmaz et al ., 2007; Valastyan and Weinberg, 2011). Matrix metalloproteinases (MMPs), a family of zinc-dependent endopeptidases, are crucial molecules in the degradation of ECM and affect the invasion of cancer cells (Khasigov et al ., 2003; Kessenbrock et al ., 2010). Among the MMPs, MMP-2 (gelatinase A) and -9 (gelatinase B) play pivotal roles in the process of ECM degradation (Vu and Werb, 2000; Egeblad and Werb, 2002).…”
Baicalein, a natural flavonoid obtained from the rhizome of Scutellaria baicalensis Georgi, has been reported to have anticancer activities in several human cancer cell lines. However, its antimetastatic effects and associated mechanisms in melanoma cells have not been extensively studied. The current study examined the effects of baicalein on cell motility and anti-invasive activity using mouse melanoma B16F10 cells. Within the noncytotoxic concentration range, baicalein significantly inhibited the cell motility and invasiveness of B16F10 cells in a concentration-dependent manner. Baicalein also reduced the activity and expression of matrix metalloproteinase (MMP)-2 and -9; however, the levels of tissue inhibitor of metalloproteinase-1 and -2 were concomitantly increased. The inhibitory effects of baicalein on cell motility and invasiveness were found to be associated with its tightening of tight junction (TJ), which was demonstrated by an increase in transepithelial electrical resistance and downregulation of the claudin family of proteins. Additionally, treatment with baicalein markedly reduced the expression levels of lipopolysaccharide-induced phosphorylated Akt and the invasive activity in B16F10 cells. Taken together, these results suggest that baicalein inhibits B16F10 melanoma cell migration and invasion by reducing the expression of MMPs and tightening TJ through the suppression of claudin expression, possibly in association with a suppression of the phosphoinositide 3-kinase/Akt signaling pathway.
“…Additionally, the results of the invasion assay showed that the invasion of CT26 and HT29 cells was attenuated by G.A treatment ( Figure 7C ). The gelatinase activity of MMP-2 and MMP-9 is closely related to the invasiveness of cancer cells (Khasigov et al, 2003). We observed that G.A reduced the expression levels of MMP-2 and MMP-9 using IF analysis ( Figure 7D ).…”
Section: Resultsmentioning
confidence: 99%
“…A typical feature of EMT is the loss of cell-cell contact by the regulation of expression of cell-cell adhesion molecules such as E-cadherin, N-cadherin, and vimentin (Thiery and Sleeman, 2006). Additionally, epithelial cancer cells become spindle shaped with increased metastatic abilities including migration and invasion by enhancing matrix metalloproteinase (MMP)-2 and MMP-9 production, which are involved in matrix remodeling-related proteolysis (Khasigov et al, 2003). …”
Gomisin A (G.A) is a dietary lignan compound from Schisandra chinensis. In this study, the effect of G.A on the proliferation and metastasis of colorectal cancer (CRC) cells was investigated using several CRC cell lines and a lung metastasis mouse model. Both oral and intraperitoneal administration of G.A (50 mg/kg) inhibited lung metastasis of CT26 cells. Various concentrations of G.A were incubated with CRC cell lines and their viability was determined using a cell counting kit-8 assay. G.A significantly decreased the viability of various CRC cell lines, whereas it did not change the proliferation of normal colon cells. G.A induced G0/G1 phase arrest and apoptosis of CT26 and HT29 cells by regulating cyclin D1/cyclin-dependent kinase 4 (CDK4) expression and apoptotic proteins such as caspases and B-cell lymphoma-2 (Bcl-2) family proteins, respectively. G.A-induced apoptosis was mediated by AMPK/p38 activation in CRC cells. A non-cytotoxic concentration of G.A inhibited epithelial–mesenchymal transition of CRC cells by modulating E-cadherin and N-cadherin expression levels. Moreover, the migration and invasion of CRC cells were reduced by G.A treatment. Especially, G.A decreased matrix metalloproteinase (MMP)-2 and MMP-9 expressions and activities. G.A ameliorated lung metastasis of CRC cells by decreasing cell survival and metastatic abilities of CRC cells. Thus, G.A might be a potential novel therapeutic agent for metastatic CRC.
Cancer cell invasion is one of the crucial events in local spreading, growth, and metastasis of tumors. The present study investigated the antiinvasive and antimetastatic action of gambogic acid (GA) in MDA-MB-435 human breast carcinoma cells. GA caused a concentration-dependent suppression of cell invasion through Matrigel and significantly inhibited lung metastases of the cells transplanted in vivo. The potent effects of GA have been attributed to its ability to reduce the expression of matrix metalloproteinases (MMP) 2 and 9 in vitro and in vivo both at the protein and mRNA levels, which were associated with protein kinase C (PKC) signaling pathway as supported by the diminished antiinvasive effect of GA in the presence of specific activator of the pathway. Collectively, our data demonstrated that GA exhibited antiinvasion properties on highly invasive cancer cells via PKC mediated MMP-2/9 expression inhibition. This indicated that GA can be served as a potential novel therapeutic candidate for the treatment of cancer metastasis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.